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A b s t r a c t  
Psoriasis is a chronic; T lymphocyte mediated autoimmune inflammatory disorder 
characterized by well-defined erythematous (reddish) plaques with large adherent silvery 
scales that affects the skin and other parts of the body. The essential oil in turmeric is anti-
inflammatory and effective in treating chronic disorders like psoriasis that have 
inflammation as a root symptom. Nanoemulsions are isotropic, thermodynamically stable 
transparent (or translucent) systems of oil, water, surfactant and co-surfactant with a 
droplet size usually in the range of 20–200 nm. Their long-term stability and ease of 
preparation (spontaneous emulsification)  make it promising tool for drug delivery.  The 
aim of this study was to obtain nanoemulsions of turmeric oil for psoriasis and to evaluate 
their physical stability, irritation potential and in vivo inflammatory activity. For the 
preparation of nanoemulsion titration method was used which was composed of 15% 
turmeric oil, 42 % Smix (1:1) and 43 % distilled water. The nanoemulsion was stable 
during the period of study and was found to be practically non-irritating in the organotypic 
HET-CAM model. The anti inflammatory activity of optimized nonoemulsion was carried 
out by carragennen induced paw edema and found to be 70.35 % inhibition. 





Psoriasis is a chronic; T lymphocyte mediated autoimmune 
inflammatory disorder characterized by well-defined erythematous 
(reddish) plaques with large adherent silvery scales that affects 
the skin, joints, and tendons in up to 2.5% of the population 
worldwide [1-3]. The main abnormality in psoriasis is an increased 
proliferation of the skin layers due to excessive division of the cell 
in the basal layers of the skin. Severe itching may associate with 
the plaques. Dryness of the skin and silvery scaling are 
characteristics of this condition. The large number of anti psoriasis 
medications currently available to treat psoriasis raises important 
questions about fetal safety if a woman with psoriasis becomes 
pregnant while taking these medications. Unfortunately, published 
information on the effects of these medications on the developing 
embryo or fetus is limited. The teratogenic risk in human 
pregnancy was found to be undetermined for 91.2% of drug 
treatments approved in the United States between 1980 and 2000 
[4]. Because of this uncertainty in risk estimation, women with 
psoriasis may be advised to use less effective treatment if they 
become pregnant or avoid treatment altogether because of 
concerns that the  treatment might cause birth defects in their 
children. So our main aim is to treat such disorder by using some 
nature source. 
Many herbs have demonstrated anti-inflammatory activity. 
Turmeric (Curcuma longa belonging to the family of 
Zingiberaceae) is a rhizome, or fleshy root, that has long history in 
both Chinese and Ayurvedic (Indian) medicine as an anti-
inflammatory agent. The essential oil in turmeric is anti-
inflammatory and effective in treating chronic disorders like 
psoriasis that have inflammation as a root symptom. Turmeric oil 
has also demonstrated as a potent anti-inflammatory activity in a 
variety of experimental animal models [5]. Curcumin in turmeric oil 
[6] inhibits leukotriene formation, inhibits platelet aggregation and 
stabilizes neutrophilic lysosomal membranes, thus inhibiting 
inflammation at the cellular level [7]. Curcumin is reported to 
possess greater anti-inflammatory activity than ibuprofen [8]. 
Pharmacological treatments for psoriasis are generally based on 
antiproliferative, anti-inflammatory, or differentiation-modifying 
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antipsoriatic drugs, turmeric oil was found to inhibit the 
keratinocyte proliferation, suggesting its potential in suppressing 
psoriasis [9].  
Turmeric oil consists of a unique set of sesquiterpenoids 
considered to have significant pharmacological activities. 
Antifungal, insect repellent, antibacterial, antimutagenic, and 
anticarcinogenic activities [10-12] of turmeric oil have been 
reported. 
Nanoemulsions are isotropic, thermodynamically stable 
transparent (or translucent) systems of oil, water, surfactant and 
co-surfactant with a droplet size usually in the range of 20–
200 nm [13-16]. Their long-term stability, ease of preparation 
(spontaneous emulsification), and high solubilization of drug 
molecules make it promising tool for drug delivery. Recently, 
much attention has been focused on the colloidal drug delivery 
systems such as microemulsions, solid lipid nanoparticles and 
liposome for topical delivery of drugs because of low side effects, 
high bioavailability, good patient compliance, etc. [17-19]. 
Nanoemulsions are well characterized and are a promising drug 
delivery system with practical applications for pharmaceutical, 
cosmetic and chemical industry applications. They have been 
used in intravenous, oral and ocular drug administrations and 
have reduced drug side effects and improved the pharmacological 
effects of the drugs given [20-22].  
The aim of this study was to obtain nanoemulsions of turmeric oil 
and to evaluate their physical stability, irritating potential and in 
vivo inflammatory activity. 
Materials and methods 
Materials 
Turmeric oil was gifted from Lala Jagdish Prasad & company, 
Kanpur, India. Polyoxyethylene sorbitan monolaurate (Tween 20), 
polyoxyethylene sorbitan monooleate (Tween 80), lecithin, 
labrasol, isopropyl alcohol were procured from S.D Fine 
Chemicals (Mumbai, India). Water was obtained from Milli Q 
water purification system (Millipore, MA). All chemicals and 
solvents were of analytical grade.  
Preparation of nanoemulsion 
For the preparation of nanoemulsion of turmeric oil the following 
surfactant and co-surfactant mixtures were evaluated to find out a 
stable nanoemulsion formulation: Tween 20/isopropyl alcohol, 
Tween 80/ isopropyl alcohol, Labrasol/ isopropyl alcohol and 
Lecithin/ isopropyl alcohol.  
The phase diagram method was used with different combination 
of surfactant and co-surfactant having 1:1 ratio in all the 
combination because only with the help of surfactant we cannot 
reduce interfacial tension [23, 24], which can produce flexible film 
for the formulation of stable nanoemulsion. Here only 1:1 ratio of 
different type of surfactants and co-surfactant was taken so that 
surfactant concentration kept at its minimum concentration 
because high concentration of Smix may cause irritation and 
toxicity to the tissues [25].  All emulsions were prepared by 
spontaneous saponification method (titration method).  
Phase studies 
For the formation of nanoemulsion, turmeric oil is used as oil 
phase, Tween 20, Tween 80, Lecithin and Labrasol used as a 
surfactant and Isopropyl alcohol used as a co-surfactant.  The 
Smix were chosen in fixed concentration (1:1) for each phase 
diagram. For each phase diagram, oil and specific S mix were 
mixed well in different ratios. Sixteen different combinations of oil 
and S mix (1:9, 1:8, 1:7, 1:6, 1:5 1:4, 1:3.5, 1:3, 3:7, 1:2, 4:6, 5:5, 
6:4, 7:3, 8:2, and 9:1) were made so that maximum ratio could be 
covered for the study to delineate the boundaries of the phases 
formed precisely in the phase diagrams [26].  Slow titration with 
aqueous phase was done for each weight ratio of oil and Smix 
under moderate stirring, and visual observation was used for 
transparent and easily flowable nanoemulsion. Gels were claimed 
for those clear and highly viscous mixtures that did not show a 
change in the meniscus after being tilted to an angle of 90°. The 
physical state of nanoemulsion was marked on a pseudo three 
component phase diagram with one axis representing the 
aqueous phase, second representing oil, and the third 
representing a mixture of surfactant and co-surfactant at fixed 
weight ratio (Smix ratio). 
Selection of formulations 
The pseudoternary phase diagrams which shows maximum 
nonaemulsion region was taken for further studies. From the 
phase diagrams, a number of nanoemulsions formulations were 
taken with different ratio of oil, Smix and water. Selected 
formulations were subjected to various physical stability tests. 
Thermodynamic stability testing of nanoemulsions 
In order to find out the stable nanoemulsion and to discard the 
unstable or metastable nanoemulsions the placebo 
nanoemulsions were subjected to following thermodynamic 
stability studies.  
Freeze thaw cycle: Nanoemulsions were kept in deep freezer (at -
20 oC) for 24h. After 24h the nanoemulsions were removed and 
kept at room temperature. The thermodynamically stable 
nanoemulsions returned to their original form within 2-3 min. 2-3 
such cycles were repeated. 
Centrifugation studies: Nanoemulsions after freeze thaw cycle 
were subjected to centrifugation studies where they were made to 
undergo centrifugation for 30 min. at 5,000 rpm in a centrifuge. 
The stable formulations did not show any phase separation or 
turbidity [27].  
Heating cooling cycle: Six cycles between refrigerator 
temperature (4 0C) and 40 0C with storage of 48 hours were 
performed. Those formulations which were stable at these 
temperature, subjected to further study.  
Characterization of nanoemulsions 
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Globule size analysis The droplet size of the nanoemulsions was 
determined by photon correlation spectroscopy, which analyses 
the fluctuations in light scattering due to Brownian motion of the 
particles using a Zetasizer 1000 HS (Malvern Instruments, 
Worcestershire, UK). Light scattering was monitored at 25°C at a 
90° angle [28]. 
Viscosity Viscosity of nanoemulsion was determined by using 
Brookfield LV rotational viscometer at 2.5, 5, 10 and 20 rpm. Each 
reading was taken after equilibrium of the sample at the end of 
two minutes. The samples were repeated three times. The 
viscosity values at 5 rpm were selected 
Refractive index The refractive index of the system was measured 
by an Abbe refractometer (Bausch and Lomb Optical Company, 
Rochester, NY) by placing one drop of the formulation on the slide 
in triplicate at 25°C. 
pH Measurements The apparent pH of the formulations was 
measured by a pH meter (Mettler Toledo MP 220, Greifensee, 
Switzerland) in triplicate at 25°C. 
Transmission Electron Microscopy (TEM) Morphology and 
structure of the nanoemulsion were studied using Morgagni 268D 
electron microscope (Fei Company, Netherlands) operating at 
70 kV capable of point-to-point resolution. Combination of bright 
field imaging at increasing magnification and of diffraction modes 
was used to reveal the form and size of the nanoemulsion. In 
order to perform transmission electron microscopy (TEM) 
observations, a drop of the nanoemulsion was suitably diluted 
with water and applied on a carbon-coated grid, then treated with 
a drop of 2% phosphotungstic acid and left for 30 s. The coated 
grid was dried and then taken on a slide and covered with a cover 
slip and observed under the microscope. 
 
In vitro Irritant test in an organotypic model - HET-CAM 
(Hen's Egg Test on the Chorioallantoic Membrane)  
The HET-CAM test is routinely used to evaluate the potential eye 
irritation of raw materials but can in some cases be used to 
evaluate skin irritation, e.g. in the case of surfactants. Irritation 
causes alterations in the vascular system of the HET-CAM that 
result in membrane discoloration, haemorrhaging and increased 
perfusion. The method used in this manuscript is a modification of 
the method described by Luepke [29] and adapted by Mehling 
[30] that allows the immediate evaluation of irritation by solid or 
liquid substances in the hen's egg chorioallantoic membrane. 
Each substance was tested on three fertilised eggs that were 
incubated for 9 days prior to testing. The CAM (Chorioallantoic 
Membrane) was exposed to 300 μL of one of the following 
substances: (1) nanoemulsion (pH 6.54), (2) surfactant solution 
blend (5% sorbitan oleate, 5% PEG-30 castor oil and 90% water 
(pH 6.32), (3) Sodium lauryl sulphate (SLS) 10% w/w (positive 
control, pH 6.05) and (4) saline solution (negative control, pH 6.0). 
The CAM was rinsed with physiological saline solution after 30 
seconds of exposure to each substance, and the intensity of the 
reactions (hyperaemia, haemorrhage and coagulation) was semi-
quantitatively assessed on a scale of 0.5, 2 and 5 minutes after 
treatment; longer observation times give no additional important 
information. The numerical time-dependent scores for 
hyperaemia, haemorrhage and coagulation are summed to give a 
single numerical value indicating the irritation potential of the test 
substance on a scale with a maximum value of 21. The mean 
value of four tests makes possible an assessment by a 
classification scheme analogous to the Draize categories (Table 
1). 
In vivo anti-inflammatory effect on carrageenan-
induced paw-edema in rats 
Paw edema can be induced by murine carrageenan. Male 
Sprague-Dawley rats weighing 150-180 g were used for the 
experiments.  The protocol to carry out animal studies was 
approved by the Institutional Animal Ethics Committee, Translam 
Institute of Pharmaceutical Education and Research, Meerut, 
U.P., India. The committee's guidelines were followed for the 
studies. All measurements were performed at 24±1°C in an air-
conditioned room. The animals were randomly divided into eight 
groups of six rats each for administration. The rats of the first 
control group were treated with normal saline [31]. The other 
seven experimental groups received different topical formulations 
of turmeric oil nanoemulsions. To induce local inflammation, 50 μ l 
of 1% carrageenan (w/v) in saline was injected into the plantar 
surface of the left hind paw of the rats at time zero, using a 27-
gauge needle coupled to a 100 ml Hamilton syringe. In the first 
experiment, 60 minutes later, turmeric oil nanoemulsions were  
applied, nonocclusively, to the paws of the animals and spread 
gently. Animals were then housed in polypropylene cages with 
framed metal mesh on the floor to prevent absorption of applied 
products by sawdust. The animals were maintained without 
access to food and water during the experiment. 
Measurements of foot volume were performed by the method 
described by [32] using water plethysmometer (LE 7500, Letica 
Scientific Instruments, Barcelona, Spain) before and 1, 2, 3, 4, 
and upto 24 hours after the injection of carrageenan into the 
planter region of the left hind paw. The degree of paw swelling 




where Vt (ml) is the volume of the carrageenan-treated paw, 
Vo is that of the nontreated paw. 
 
On the basis of equation (1), the percentage edema inhibition was 
calculated as 
 
Inhibition (%)= 1-%swelling of thenanoemulsion treatrd group / 
swelling of the control group X100 
(2) 
Histopathology studies 
Abdominal skin of Wistar rats was treated with the optimized 
turmeric oil nanoemulsion A3. After 24 h, the rats were killed and 
skin samples were taken from untreated (control) and treated 
areas. Each specimen was stored in 10% formalin solution in 
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phosphate buffer saline (pH 7.4). The specimens were cut into 
sections vertically. Each section was dehydrated using ethanol 
embedded in paraffin wax for fixing and stained with hematoxylin 
and eosin. These samples were then observed under light 
microscope (Motic, Japan) and compared with control samples 
[33]. 
Stability studies of optimized formulation 
Stability studies on optimized nanoemulsion were performed by 
keeping the sample at 4  ± 0.5 0C,  25 ± 0.5 0C and 40 ± 0.5 0C. 
These studies were performed for the period of 3 months. The 
droplet size, viscosity, pH, refractive index and electrical 
conductivity were determined at 0, 1, 2 and 3 months.  
Results and discussion 
The most important criteria for selection of all the nanoemulsion 
components is that all the excipients should be pharmaceutically 
acceptable for topical application, depending upon the 
requirement and falling under the generally-regarded-as-safe 
category. 
Screening criteria for oil selection 
In this study only turmeric oil was selected for the formulation of 
nanoemulsion because this oil considered as a active substance 
for the treatment of psoriasis. There is no any drug used so 
solubility study was omitted.  
Screening criteria for surfactants 
The most critical problem related to the nanoemulsion-based 
systems is the toxicity of the components. Large amounts of 
surfactants may cause skin irritation when administered topical. 
So the proper selection of surfactants becomes necessary. It is, 
therefore, important to determine the surfactant concentration 
properly and use the minimum concentration in the formulation. 
Nonionic surfactants are relatively less toxic than their ionic 
counterparts and typically have lower CMCs. Also, o/w 
nanoemulsion dosage forms for topical use based on nonionic 
surfactants are likely to offer in vivo stability [34]. Therefore, 
proper selection of surfactants becomes a crucial factor. Another 
important criterion is the selection of surfactant with proper HLB 
value. Hydrophilic surfactant and co-surfactant are considered to 
prefer the interface and to lower the necessary energy to form the 
nanoemulsions, as a result improving the stability. For example, 
the required HLB value to form o/w nanoemulsion is greater than 
10 [35]. The right blend of low and high HLB surfactants leads to 
the formation of a stable nanoemulsion upon dilution with water. 
After selection of oil phase, the main aim was to identify the 
surfactant that has the highest solubilization capacity for the oil. In 
the present study, four surfactants, namely, Tween 20, Tween 80, 
Lecithin, and Labrasol were chosen for screening. Nonionic 
surfactants were selected since they are known to be less 
affected by pH and changes in ionic strength, are generally 
regarded as safe, and are biocompatible. Ionic surfactants were 
excluded from the study due to toxicological concerns. Here, we 
have selected the surfactant giving the maximum nanoemulsion 
formulation in phase diagram.  
Screening of co-surfactants 
From literature we know that only surfactants are responsible for 
the formulation of nanoemulsion, the role of cosurfactant is to 
reduce further interfacial tension to make nanoemulsion more 
stable by providing flexible film. Isopropyl alcohol was selected as 
a co-surfactant because it is used for topical delivery and also act 
as a penetration enhancer.and also it comes under GRAS 
category. 
Preparation of pseudo ternary phase diagram 
Formulations were carefully observed so that the metastable 
systems were not selected, although the free energy required to 
form a nanoemulsion is very low and the formation is 
thermodynamically spontaneous [36]. On the basis of 
psedoternary phase diagram lecithin and isopropyl alcohol (1:1) 
was selected for further study because this combination of 
surfactant and co-surfactant able to produce maximum 
nanoemulsion area (Figure. 1). When co-surfactant was added 
with surfactant in equal amounts, a higher nanoemulsion region 
was observed, perhaps because of the further reduction of the 
interfacial tension and increased fluidity of the interface 
at Smix 1:1. Further increase of Smix ratio was not studies 
because high surfactant may cause irritation. 
Thermodynamic stability tests of nanoemulsion 
In order to exclude the possibility of metastable formulations, 
stress testing is required. Some representative formulations were 
taken from the o/w nanoemulsion region of the phase diagram 
constructed at Smix 1:1 for lecithin and isopropyl alcohol,  and 
were subjected to the thermodynamic stability tests such as 
heating cooling cycle, freeze thaw cycle, and centrifugation.  
Results of thermodynamically stable formulations were shown in 
(Table 2). Thermodynamic stability test confers long term stability 
to the nanoemulsion as compared to ordinary emulsions. It 
differentiates them from emulsions that have kinetic stability and 
will eventually phase-separate [37]. Thermodynamically stable 
formulations were selected for further studies. 
Characterization of the Selected Nanoemulsions 
The nanoemulsions were selected for further optimization which 
all ready passed stress test.  
Globule size analysis The droplet size increased with increase in 
the concentration of the oil in the formulations (Table 3). However, 
the droplet size of all the formulations was in the nano range. The 
low polydispersibility values observed for all the formulations 
indicated uniformity of droplet size within each formulation.  
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The droplets in the nanoemulsion appear dark, and the 
surroundings are bright; a “positive” image was seen using TEM 
(Figure 2 and Figure 3). Some droplet sizes were measured using 
TEM, as it is capable of point-to-point resolution. The uniformity of 
particles size was investigated with the help of size distribution 
analysis as shown in (Figure 4 and Figure 5). 
Viscosity Viscosity tends to increase with the oil content. As the oil 
content was increased from 5% w/w to 25% w/w, an increase in 
the viscosity of the formulations was observed (Table 3). The 
viscosity of formulation A2 was significantly lower than that of the 
other formulations (p < 0.05), which might be due to its lower oil 
content. Overall, very low viscosity of the formulations was 
observed, which is expected for nanoemulsions. 
pH Measurements The apparent pH of all formulations were 
measured by pH meter in triplicate at 25 ± 1°C and found to in 
between 5-6 (Table 3). This pH range is optimum for topical 
formulation.  
Refractive index Refractive index is the net value of the 
components of nanoemulsion and indicates the isotropic nature of 
the formulation. The mean value of the refractive index for all the 
formulations was given in (Table 3). The lowest values of RI was 
seen in A2 formulation, might be due to a increase in water 
content, as water has a comparatively lower refractive index (the 
refractive index of water is 1.334). 
 
In vitro Irritant test in an organotypic model - HET-CAM 
(Hen's Egg Test on the Chorioallantoic Membrane)  
Topical application products must have a low ocular/ mucous 
membrane and a low dermal irritation potential. 
The irritation potential depends on the concentration of the 
substance as well as the chemical composition and the pH of the 
formulation [38]. 
The HET-CAM test can help evaluate the irritation potential of 
substances in vitro and in vivo [39]. The CAM showed no signs of 
irritation after application of either the nanoemulsion or the 
negative control substance, so the nanoemulsions were therefore 
considered practically non-irritating. The surfactant solution by 
itself caused mild hyperaemia, which suggests that the presence 
of turmeric oil in the nanoemulsion may have protected the 
chorioallantoic membrane from the irritating effects of the 
surfactant solution (Table 4). The pH values were the same for all 
samples tested to eliminate pH as a variable in the HET-CAM 
results. 
The HET-CAM test showed that the nanoemulsions containing 
turmeric oil was essentially non-irritating. 
In vivo anti-inflammatory effect on carrageenan-
induced paw-edema in rats 
The formulations A2 and A3 were chosen for the in vivo study due 
to its high stability and lack of irritation in the HET-CAM test. The 
anti-inflammatory effects of optimized formulations were 
compared with the control.  The anti-inflammatory activity of 
optimized formulations of nanoemulsion was evaluated using the 
carrageenan-induced hind paw edema method using digital 
Plethysmometer. The rat's left footpad became edematous soon 
after injection of carrageenan and reached its peak at 3 h (75.2 
%). Mean percent edema and % inhibition of inflammation of all 
the three groups were calculated which was shown in Figure 6. 
Inhibition of edema was found to be highest in the groups in which 
nanoemulsion A3 was applied. The nanoemulsions A2 and A3 
inhibited edema (P < 0.05) 62.33% and 70.35 % respectively up 
to 24 h. Control formulation inhibited the edema 42.98 % up to 24 
h. Based on the anti-inflammatory studies, it can be concluded 
that A3 formulation shows maximum inhibition of edema than the 
A2 formulation and the control.  
Histopathology studies  
The influence of turmeric oil nanoemulsion on anatomical 
structure of the rat skin was assessed with the help of 
histopathological studies. After observation of light power 
photomicrograph of control and treated skin (Figure 7), it was 
found that no significant different was seen in the shape and size 
of the tissue of rat skin.  
Stability study 
The formulation A3 was tested at three different storage 
temperatures: 4 ± 0.5°C, 25 ± 0.5°C and 40 ± 0.5°C. Droplet size 
measurements are a good indicator of the formulation stability. A 
fast droplet size increase indicates low system stability. The 
droplet size for this formulation remained constant over 90 days 
for all temperature conditions (Figure 8). The nanoemulsions had 
polydispersity index values below 0.2 throughout the 90-day 
testing period, indicating the high fidelity of the system (low 
polydispersity), which may reflect the overall stability of this 
formulation and synthesis method. Polydispersity values near 1.0 
are indicative of a polydisperse system. The long term stability of 
nanoemulsions was previously evaluated and was also verified by 
stability studies conducted over three months. The O/W 
nanoemulsion produced by low energy emulsification showed no 
difference in droplet size over the study period at both 25°C and 
4°C.  
The long term stability of nanoemulsions was previously 
evaluated and was also verified by stability studies conducted 
over three months. The O/W nanoemulsion produced by low 
energy emulsification showed no difference in droplet size over 
the study period at both 25°C and 4°C [40]. The O/W 
nanoemulsion demonstrated high physical stability, corroborating 
our results for temperatures of 4 ± 0.5°C and 25 ± 0.5°C. Low-
energy emulsification is better at producing stable nanoemulsions 
than its higher energy counterpart. When nanoemulsions were 
prepared using a high pressure homogeniser, the droplet size was 
initially around 56 nm; however, the particles slightly increased in 
size after 30 days at either 25 or 4°C. The low-energy 
emulsification method used in our study showed high stability with 
respect to the droplet size and polydispersity index. 
The viscosity and RI were also determined at 40C, 250C and 
400C. These parameters were determined at 0, 1, 2 and 3 
months. It was found that viscosity and RI were slightly increased 
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in time at all temperatures (Figure 9 and Figure 10). These 
parameters were compared for statistical significance by one-way 
analysis of variance (ANOVA) followed by Tukey-Kramer multiple  
 
 
Table 1: Classification of cumulative scores in the chorioallantoic membrane test (According Luepke 1985) [29] 
 
Cumulative Score Irritation assessment 






Table 2: Composition of selected nanoemulsion 
 
Oil used: Turmeric oil, Surfactant used: Lecithin, 











H/C Cent Freeze Result 
1:1 A1 5 33 62 √ √ X Failed 
A2 10 38 52 √ √ √ Passed 
A3 15 42 43 √ √ √ Passed 
A4 20 47 33 √ √ √ Passed 




Table 3: Characteristics of the turmeric oil nanoemulsions 
 
Formulation Code Mean Globule 
Size (nm) 
Poly dispersivity Viscosity (mP) pH Refractive Index Electrical 
Conductivity 
(µs/cm) 
A2 31.52 0.157 38.44± 1.17 5.9 ± 0.03 1.431 ± 0.011 121 
A3 56.05 0.192 41.41 ± 1.32 6.1 ± 0.02 1.463 ± 0.013 116 
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Figure 2: TEM photograph of particle size of nanoemulsion (A2) 
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Figure 4: Droplet size and size distribution of nanoemulsion formulation (A2). 
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Figure 6: Comparison of anti-inflammatory activity of turmeric oil nanoemulsions A2 and A3 with control 
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Figure 8: Nanoemulsion mean droplet size under different storage conditions during a 90-day stability test. 
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Figure 10: Refrective index of nanoemulsions over time under different storage conditions.  
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Figure11: pH of nanoemulsions over time under different storage conditions.  
  
Figure 12: Electrical conductivity of nanoemulsions over time under different storage conditions.  
 
 
comparisons test using GraphPad Instat software (GraphPad 
Software Inc., CA, USA). The changes in these parameters were 
not statistically significant (P≥ 0.05). Monitoring the pH value is 
important for determining the emulsions’ stability because pH 
changes indicate the occurrence of chemical reactions that can 
compromise the quality of the final product. Emulsions produced 
with vegetable oils may experience a decrease in pH due to the 
hydrolysis of fatty acid esters into free fatty acid degradation 
products [41]. 
The nanoemulsions had stable pH values for almost all conditions 
tested (Figure 11). Only at a temperature of 40 ± 0.5°C and 90 
days of incubation was there a statistically significant decrease in 
the pH of the nanoemulsion. The high temperature might have 
destabilised the nanoemulsion by hydrolysis, but it did not affect 
the overall quality of the nanoemulsions because the pH values 
remained around pH 6.0, which is an acceptable, non-skin 
irritating pH value. The nanoemulsion showed changes in 
electrical conductivity at all storage conditions (Figure 12). 
Changes in the electrical conductivity can indicate nanoemulsion 
instability and may influence the nanoemulsion droplet size. In 
these studies, changes in electrical conductivity did not affect the 
nanoemulsion droplet size (Fig 8). It is difficult to assess the 
emulsion stability solely by electrical conductivity because the 
relationship between an increase in electrical conductivity and 
emulsion instability is not linear [42]. Thus, we could not 
conclusively determine the nanoemulsion’s stability by this 
parameter. However, because the particle size and the pH value 
did not significantly change across different conditions, we 
considered our nanoemulsion to be stable.               
Summary and Conclusion 
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For the preparation of nanoemulsion titration method was used 
which was composed of 15%,  turmeric oil, 42 % Smix (1:1) and 43 
% distilled water. The nanoemulsion was stable during the period 
of study and was found to be practically non-irritating in the 
organotypic HET-CAM model. The non-irritation of the optimized 
formulation was also confirmed by histopathological study using 
rat skin.  The anti inflammatory activity of optimized nonoemulsion 
was carried out by carragennen induced paw edema and found to 
be 70.35 % inhibition.  This nanoemulsion could serve as an 
alternative treatment for skin diseases such as atopic dermatitis 
and psoriasis. 
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